3-aminophenol

We are 3-aminophenol CAS:591-27-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-aminophenol
CAS.NO:591-27-5
Synonyms:3-amino-phenol; Fouramine EG; m-Hydroxyaniline;
Molecular Formula:C6H7NO
Molecular Weight:109.12600
 
Physical and Chemical Properties:
Density:0.99;
Melting point:121oC;
Boiling point:164oC;
Flash point:155oC;
 
Specification:
Appearance:Off-white crystalline powder
Purity(HPLC):≥99.0%
Ash:≤0.1%
Loss on drying:≤0.5%
Fe content:≤50ppm
Heavy metal:≤10ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate
 

3-aminophenol


Related News: Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.87199-17-5 In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.(1R, 3s, 5S) -8-bencil-3- (3-isopropil-5-metil-4H-1,2,4-triazol-4-il) -8-azabiciclo [3.2.1] octano CAS:423165-13-3 According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates.4-Fluoro-3-(trifluoromethyl)aniline ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.

Related Products
Product Name
Imidazo[1,2-a]pyridine-3-acetic acid methyl ester View Details
N-(5-Chloro-2-methylphenyl)-3-hydroxynaphthalene-2-carboxamide View Details
(4S,5R)-3-Benzoyl-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid View Details
1-Chlorobutane manufacturer Methyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate manufacturer N-(2-Hydroxyethyl)-3,4-Methylenedioxyaniline Hydrochloride manufacturer Methyl 2-(3-(3-((7-chloroquinolin-2-yl)(thiophen-2-yl)methyl)phenyl)-3-oxopropyl)benzoate manufacturer methyl 4-(butanoylamino)-3-methylbenzoate manufacturer